This brand name is authorized in the following countries: Tunisia

Active ingredients

The drug PRIFAL contains one active pharmaceutical ingredient (API):


Prifinium is an anticholinergic preferably acting at muscarinic receptors in the gastrointestinal tract. It corrects chlorhydropeptique hypersecretion, gastrin, pancreatic.

Read about Prifinium

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Prifinium bromide
A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS → A03AB Synthetic anticholinergics, quaternary ammonium compounds
Discover more medicines within A03AB18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Identification scheme
Direction de la Pharmacie et du Mรฉdicament
Identifier(s): 9254151

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.